Fieldview Capital Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2040221
NILES, MI
Position in ALNY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,745,339
-$4,026,709 QoQ
Shares Held
5,275
-58.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fieldview Capital Management, LLC holds $11,886,724 across 19 Biotechnology names. ALNY ranks #2 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
41,310 | $1,981,640 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
5,275 | $1,745,339 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
49,204 | $932,907 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,555 | $724,498 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,832 | $723,520 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
14,648 | $720,095 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
44,948 | $649,948 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
3,400 | $642,770 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,745,339 | 5,275 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $5,772,048 | 12,658 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||